Search Media Items

Treatment options for children with Hodgkin lymphoma use risk-adapted, response-based paradigms to determine treatment length and intensity. Get detailed treatment information for new and recurrent classical and nodular lymphocyte predominant Hodgkin lymphoma in this clinician summary.

Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Get detailed information about newly diagnosed and recurrent NSCLC in this summary for clinicians.

Paranasal sinus and nasal cavity cancer treatment often is a combination of surgery and radiation therapy for operable tumors. Chemotherapy may be used as palliation in recurrent disease. Get detailed treatment information for newly diagnosed and recurrent disease in this clinician summary.

Lip and oral cavity cancer treatment can include surgery, radiation therapy, or both, depending on the site and extent of the primary tumor. Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent laryngeal cancer in this summary for clinicians.

Myelodysplastic syndromes (MDS) treatment options include supportive care, disease-modifying agents, and allogeneic stem cell transplantation. Get detailed information about the treatment of newly diagnosed and recurrent MDS in this summary for clinicians.

Chronic Myeloproliferative Neoplasms (MPN) treatment varies widely depending on the specific diagnosis. Treatment options may include observation, phlebotomy, steroids, chemotherapy, immunotherapy, and stem cell transplant. Get detailed information about MPNs in this summary for clinicians.

Hairy cell leukemia treatment options include surveillance, chemotherapy, targeted therapy/immunotherapy, and splenectomy. The decision to treat is based on cytopenias, splenomegaly, or infectious complications. Get detailed information about hairy cell leukemia in this clinician summary.

Urethral cancer treatment generally relies upon surgery. Radiation therapy and/or chemotherapy is sometimes used with extensive disease or in an attempt at organ preservation. Get detailed treatment information for newly diagnosed and recurrent disease in this clinician summary.

Oropharyngeal cancer treatment options may include radiation therapy, surgery, chemoradiation, chemotherapy alone, and immunotherapy. Get detailed information about the treatment for newly diagnosed and recurrent oropharyngeal cancer in this summary for clinicians.

For acute lymphoblastic leukemia (ALL), the 5-year survival rate has improved significantly since 1975. Get information about risk factors, signs, diagnosis, molecular features, survival, risk-based treatment assignment, and induction and postinduction therapy for children and adolescents with newly diagnosed and recurrent ALL.

Laryngeal cancer treatment options depend on the location and extent of disease, often includes surgery and/or radiation, and sometimes chemotherapy. Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent laryngeal cancer in this summary for clinicians.

Hypopharyngeal cancer treatment options include surgery and/or radiation therapy, and sometimes chemotherapy. Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent hypopharyngeal cancer in this summary for clinicians.

Salivary gland cancer treatment options include surgery with or without postoperative radiation therapy, radiation therapy, and chemotherapy. Get detailed information about the treatment for newly diagnosed and recurrent salivary gland cancer in this summary for clinicians.

Metastatic squamous neck cancer with occult primary treatment options include surgery, radiation therapy or a combination of both. Get detailed information about newly diagnosed or recurrent metastatic squamous neck cancer in this summary for clinicians.

Nasopharyngeal cancer treatment options include radiation therapy, chemoradiation followed by adjuvant chemotherapy, surgery, and chemotherapy. Get detailed information about the treatment of newly diagnosed and recurrent nasopharyngeal cancer in this summary for clinicians.